News

artificial intelligence AI heart cardiology

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.

William P. Shutze, MD, FACS, secretary of the Society of Vascular Surgery (SVS), a vascular surgeon with Texas Vascular Associates in Plano, Texas, and a clinical associate professor of medicine at Texas A&M College of Medicine, explains the goals of the SVS quality assessment program.

SVS quality initiative gathers data to improve vascular care

More than 7,000 physicians from a wide variety of healthcare specialties are already participating in the project.

Radiologists countersue former colleague over delayed $2M payout in sale to private equity

Orchard Park, New York-based Southtowns Radiology Associates and eight of its doctors filed the suit against Gregory R. Ball, MD, PhD, on April 3.

Weill Cornell Medicine plans $57M new radiology center in Brooklyn

The New York City academic system officially applied for the necessary state Department of Health approvals on April 6.

Radiology departments can cut costs and save the planet by limiting ultrasound waste

The modality uses a high volume of linens, gels and other disposable supplies that also can have a significant global carbon footprint in radiology, experts note.

Former Amazon One Medical doctor alleges she was fired for reporting patient safety issues

Sue Kim, MD, a primary care provider who worked for One Medical for more than a decade, claims in a lawsuit that she was fired for reporting patient safety incidents to a supervisor, which spurred the company to launch a targeted investigation designed to discredit her. Amazon, the parent company of One Medical, disputes Kim’s story.

Medicare navigation company raises $100M to improve its AI, launch new financial products

Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.

Dying former US senator: ‘Will AI bring heaven or hell? Yes.’

Ben Sasse is showing the effects of the terminal pancreatic cancer he was diagnosed with late last year. Yet he’s still in good spirits and his mental energy remains high.

Medicare delays prior authorization pilot program for key interventional radiology service

CMS officially announced the move on April 6, with it applying to the Wasteful and Inappropriate Service Reduction (WISeR) Model.

Therapy-related acute myeloid leukemia is an aggressive form of blood cancer and bone marrow that occurs in the years following radiation and chemotherapy.

Anthem expands policy that punishes hospitals who use out-of-network radiologists into new state

The insurer (also known as Elevance) first launched its new “nonparticipating care providers” policy across 11 states beginning on Jan. 1, drawing widespread criticism.

To unpack the large number of lat-breaking trials at the American College of Cardiology 2026 meeting, Cardiovascular Business spoke in the above video interview with Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, director of the Mount Sinai Fuster Heart Hospital, who highlighted several studies he felt had the most scientific impact. This included a mix of drug, device and strategy trials pointing to advances in cardiology. #ACC #ACC26

Deepak Bhatt discusses some of the most impactful trials at ACC 2026

Bhatt describes a mix of drug, device and strategy trials pointing to advances in cardiovascular science.

Around the web

Cardiovascular Business

FDA clears new AI model for detecting signs of cardiac amyloidosis

This is the second FDA clearance in two weeks for Massachusetts-based Anumana. The company's AI models are built to evaluate ECG results for signs of various cardiovascular conditions.